Log In
BCIQ
Print this Print this
 

Gamunex, immune globulin intravenous

  Manage Alerts
Collapse Summary General Information
Company Grifols S.A.
DescriptionImmune globulin intravenous (IGIV)
Molecular Target Not available
Mechanism of ActionNA
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$3,400.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/13/2011

$3,400.0M

Undisclosed

0

Get a free BioCentury trial today